Overview
Aventra 3% Sodium Chloride Infusion is a specialized hypertonic saline solution manufactured by Fidson Healthcare PLC. Unlike standard "Normal Saline" (0.9%), this 3% concentration is a high-alert medication used in critical care settings to manage severe electrolyte imbalances and neurological emergencies. It is primarily indicated for the rapid correction of severe, symptomatic hyponatremia and the reduction of elevated intracranial pressure (cerebral edema).
Key Uses and Benefits
- Severe Hyponatremia: Specifically formulated to restore sodium levels in patients with dangerously low blood sodium.
- Cerebral Edema Management: Helps reduce brain swelling by creating an osmotic gradient that draws excess fluid from brain cells into the bloodstream.
- Osmotic Balance: Provides 513 mEq/L of Sodium and Chloride ions, making it significantly more concentrated than standard IV fluids.
Administration and Safety
Aventra 3% is a hypertonic solution with an osmolarity of approximately 1,027 mOsmol/L. Due to its concentration:
- Medical Supervision: This infusion must only be administered by trained healthcare professionals in a clinical environment.
- Infusion Site: It is typically administered through a large central vein to minimize the risk of venous irritation or thrombophlebitis.
- Monitoring: Continuous monitoring of serum electrolytes and fluid balance is mandatory during treatment to prevent overcorrection or fluid overload.
Precautions
Use with extreme caution in patients with congestive heart failure, severe renal impairment, or conditions associated with sodium retention and edema. Rapid correction of hyponatremia can lead to serious neurological complications, such as Osmotic Demyelination Syndrome (ODS).
For clinical advice or to confirm availability for hospital use, you can contact a GoMed pharmacist.